Company Overview
Aspire Pharma Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Tuesday 24 February 2009, so this is a well established company. Aspire Pharma Limited has been in business for 17 years and 1 month. The accounts status is full and the accounts are next due on Wednesday 30 September 2026.
Registered Address

102 High Street, Godalming, Surrey, GU7 1DS
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameASPIRE PHARMA LIMITED
Company Number06828501
Registered Office Address102 High Street
 GU7 1DS
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date24/02/2009
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategoryFULL
Returns Next Due Date22/03/2017
Returns Last Made Up Date22/02/2016
Directors & Members
Show Resigned
Gary Buckley - Director
(British, 40 years old, born February 1986)
Appointed 15 June 2020
 Active
Richard Condon - Director
(British, 50 years old, born August 1976)
Appointed 28 April 2023
 Active
Jonathan May - Director
(British, 56 years old, born April 1970)
Appointed 15 June 2020
 Active
Secretaries
Show Resigned
Gary Buckley - Secretary
Appointed 15 June 2020
 Active
Other Company Directorships
Gary Buckley
AITMA LIMITED
ALVEDIUS LTD
APHL 1 LIMITED
APHL 2 LIMITED
APHL 3 LIMITED
ASPIRE PHARMA HOLDINGS LIMITED
ATTENTIVE PHARMA LIMITED
CENOTE PHARMA LIMITED
CHARLWOOD PHARMA LIMITED
DERMATO LOGICAL LIMITED
MORNINGSIDE HEALTHCARE LIMITED
MORNINGSIDE PHARMACEUTICALS LIMITED
SAINT-GERMAIN PHARMA LTD
Richard Condon
AITMA LIMITED
ALVEDIUS LTD
APHL 2 LIMITED
CENOTE PHARMA LIMITED
CHARLWOOD PHARMA LIMITED
HORIZON PROPCO LIMITED
MORNINGSIDE HEALTHCARE LIMITED
MORNINGSIDE PHARMACEUTICALS LIMITED
SAGARES LTD
SAINT-GERMAIN PHARMA LTD
Jonathan May
AITMA LIMITED
ALVEDIUS LTD
APHL 1 LIMITED
APHL 2 LIMITED
APHL 3 LIMITED
ASPIRE PHARMA HOLDINGS LIMITED
CENOTE PHARMA LIMITED
CHARLWOOD PHARMA LIMITED
DERMATO LOGICAL LIMITED
HORIZON PROPCO LIMITED
MORNINGSIDE HEALTHCARE LIMITED
MORNINGSIDE PHARMACEUTICALS LIMITED
SAINT-GERMAIN PHARMA LTD
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Balance Sheet
Fixed Assets 12,449,381 12,449,381 13,123,308
Current Assets 52,678,925 52,678,925 47,566,857
Creditors Due Within One Year 16,911,355 16,911,355 14,246,917
Working Cap 35,767,570 35,767,570 33,319,940
Total Assets Less Current Liabilities 48,216,951 48,216,951 46,443,248
Long-term Liabilities 48,116,949 48,116,949 46,343,246
Net Assets 100,002 100,002 100,002
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 100,002 100,002 100,002
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Tangible Fixed Assets - - -
Fixed Assets 19.1% 19.1% 21.6%
Stocks Inventory - - -
Debtors 41.6% 41.6% 37.9%
Cash Bank In Hand 13.6% 13.6% 15.1%
Current Assets 80.9% 80.9% 78.4%
Creditors Due Within One Year 26.0% 26.0% 23.5%
Net Current Assets Liabilities 54.9% 54.9% 54.9%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 0.2% 0.2% 0.2%
Capital Employed - - -
Total Assets Less Current Liabilities 74.0% 74.0% 76.5%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Liquidity Ratio 3.1 3.1 3.3
Solvency Ratio 1.0 1.0 1.0
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 4
Mortgages Outstanding 1
Mortgages Part Satisfied 0
Mortgages Satisfied 3
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Assets 65,128,306 65,128,306 60,690,165
Debt 65,028,304 65,028,304 60,590,163
Net Assets/Debt 100,002 100,002 100,002

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company as inferred by the balance sheet the amount of net assets represents a slender margin of cover over total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company as inferred by the balance sheet the amount of net assets represents a slender margin of cover over total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company as inferred by the balance sheet the amount of net assets represents a slender margin of cover over total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around GU7 1DS
ASPIRE PHARMA HOLDINGS LIMITED
6th Floor, 2 London Wall Place, London, GU7 1DS
PHARMASCIENCE (UK) LIMITED
102 High Street, Godalming, Surrey, GU7 1DS
JUNO PHARMA UK LTD
102 High Street, Godalming, Surrey, GU7 1DS
WORLD BALL COMPANY LIMITED
102 HIGH STREET, GODALMING, SURREY, GU7 1DS
NUTHATCH CONSULTING LIMITED
102 HIGH STREET, GODALMING, SURREY, GU7 1DS
PREMIUM WORLD LIMITED
2nd Floor, Shaw House, 3 Tunsgate, Guildford, Surrey, GU7 1DS
BALLAWAPPAS LIMITED
102 HIGH STREET, GODALMING, SURREY, GU7 1DS
ATTENTIVE PHARMA LIMITED
6th Floor 2 London Wall Place, London, GU7 1DS
Document Filings
Confirmation statement made on 22 August 2025 with no updates
Confirmation statement made on 22 August 2024 with no updates
Memorandum and Articles of Association
Resolutions
Confirmation statement made on 22 August 2023 with no updates
Director's details changed for Mr Jonathan Charles May on 28 April 2023
Director's details changed for Mr Gary David Buckley on 28 April 2023
Appointment of Mr Richard Michael Condon as a director on 28 April 2023
Confirmation statement made on 28 August 2022 with no updates
Registration of charge 068285010004, created on 1 December 2021
Termination of appointment of Craig Podolsky as a director on 3 September 2021
Termination of appointment of Mark Derek Roberts as a director on 3 September 2021
Termination of appointment of Ian Jacobson as a director on 3 September 2021
Termination of appointment of Graham Julian Fraser-Pye as a director on 3 September 2021
Confirmation statement made on 28 August 2021 with no updates
Satisfaction of charge 068285010002 in full
Satisfaction of charge 068285010003 in full
Confirmation statement made on 28 August 2020 with updates
Appointment of Mr Craig Podolsky as a director on 15 June 2020
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free